Member Info for Pharma3

DX sells this month.. £32m😉

#avct😉

Can we have a day without mentioning any of the FUD?

It makes zero difference to any SP outcome.

Lots on here provide decent research..

Those who mention the FUD are obviously involved or just want more ticks for there rating…

I reckon watching2 won’t be able to cope..

Apart from the FUD trying to reel you all in…

Who will respond to them first?

Let’s leave it here..

No replies required, let’s see!

Obviously with specialist institutional investers..

It really feels like it..

Building the company into one of the big pharmas!

It’s going to take time and execution. Why not?

#Holy grail

#letsdothis

# chemowithoutcompromise

Said it from the beginning… it’s going all the way!

“It may come as nonsensical to some on here, but not every player in the cancer industry would like a cure, because they are raking off profits so huge that it would put a spanner in the cashcow...”

Let’s just say that patients of a certain age (middle age) can only take a cumulative dose of 6 rounds of dox before the heart can’t handle it anymore. End of!

With the new precision targeting of the AVA6000, a lot more dox can be used. Still no MTD found..

Not only can it be used for the Middle Aged patients but for ALL age groups…

This would imply a lot more drug sales… Equalling a lot more revenue…

So your bull**** story make zero sense in this aspect!

Try again pal!

Happy new year!

If Andy Bechtolsheim is one of those private US investers😁😉

BV, I personally know someone on the trail for TNBC,

Screened back in early Oct.

Obviously giving their ‘shorter’ mates an opportunity to get out..

Plenty of back handers in this game!

More secretive now than ever before!

Agree thompi..

But you say WE need to be realistic.. I think the company need to be realistic instead of using these phrases… it’s carrot after carrot.. ondo be overtaking Avacta soon!

End of October for new cfo.. mistake

They do love to keep the carrot dangling by using many phrases like.

‘Imminent sale’

‘Shortly’

‘In due course’

‘Communication to our shareholders’

The new CFO was meant to be handing over at the end of march..

It’s becoming very frustrating…

Having the holy grail and not winning anything again with Scrip awards.

It does make you question what the f**k is going on…

We had more RNS’s from AS

BEST ONCOLOGY R&D ADVANCE

Avacta’s pre|CISION technology-based AVA6000 chemotherapy

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in acquiring external products with the potential to launch in the near term.

https://www.fiercepharma.com/pharma/bms-merck-amgen-and-more-must-pursue-ma-offset-looming-patent-lapses-leerink

Avacta technology delivers cytotoxic drugs directly to the tumor while protecting healthy tissue

Absolutely incredible. Keeps getting better and better

Enough said.. it’s happening! It’s in the title!

Not tonight ES!

Bickering you lot and look fwd to tomorrow!

The strategic collaboration will provide Avacta access to Tempus’ multimodal datasets comprising primary tumor samples and associated clinical data from over 200,000 patients across a broad range of cancer indications. The collaboration is designed to leverage these data to characterize the deep biology of the tumor microenvironment and fibroblast activation protein (FAP) activity upon which its pre|CISION® technology is based.